Statins found to enhance efficacy of chemotherapy drug in blood cancers

June 14, 2018 by Bob Yirka, Medical Xpress report
Credit: CC0 Public Domain

A team of researchers with members affiliated with several institutions in the U.S. has found that some statins could enhance the efficacy of a chemotherapy drug used to fight blood cancers in mouse models. In their paper published in the journal Science Translational Medicine, the group describes their study of statins used with the chemotherapy drug venetoclax and what they found.

Statins are a group of drugs that are administered to patients to reduce fats in the blood. They are typically used to reduce levels of triglycerides and cholesterol, fats associated with heart attacks and strokes. In this new effort, the found that they might also be useful for treating some .

Prior research has shown that statins promote apoptosis (natural cell death) in some types of cancers—a finding that suggests they might be useful for treating those forms of cancer. In their work, the researchers found that the statin simvastatin enhanced the efficacy of venetoclax in fighting chronic lymphocytic leukemia in mouse models. It helped, they discovered, by increasing apoptosis signaling in cancer cells, resulting in less lymphoma. The result was an increase in survival times. They note also that they found stronger results than if either drug were administered alone.

Emboldened by their findings, the researchers looked at data from three prior clinical trials involving testing venetoclax for use in treating . They specifically sought out data regarding patients who had also been given statins to reduce fats in the blood. They found that those patients saw a better response against their cancer than those who did not take the . They noted also that such patients were 2.7 times more likely to see complete remission.

If statins work the same in humans, the researchers suggest, clinical use could begin quite soon since statins have already been approved by the FDA—millions of people around the world use them regularly to keep cholesterol levels down. In addition to reducing fats in the blood, they have also been shown to have few side-effects. The researchers believe clinical trials should be conducted to find out if statins could improve the outcomes of patients with leukemia and other blood cancers.

Explore further: Statins do not benefit patients with lung cancer, new study shows

More information: Statins enhance efficacy of venetoclax in blood cancers, Science Translational Medicine  13 Jun 2018: Vol. 10, Issue 445, eaaq1240 , DOI: 10.1126/scitranslmed.aaq1240

Abstract
Statins have shown promise as anticancer agents in experimental and epidemiologic research. However, any benefit that they provide is likely context-dependent, for example, applicable only to certain cancers or in combination with specific anticancer drugs. We report that inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) using statins enhances the proapoptotic activity of the B cell lymphoma-2 (BCL2) inhibitor venetoclax (ABT-199) in primary leukemia and lymphoma cells but not in normal human peripheral blood mononuclear cells. By blocking mevalonate production, HMGCR inhibition suppressed protein geranylgeranylation, resulting in up-regulation of proapoptotic protein p53 up-regulated modulator of apoptosis (PUMA). In support of these findings, dynamic BH3 profiling confirmed that statins primed cells for apoptosis. Furthermore, in retrospective analyses of three clinical studies of chronic lymphocytic leukemia, background statin use was associated with enhanced response to venetoclax, as demonstrated by more frequent complete responses. Together, this work provides mechanistic justification and clinical evidence to warrant prospective clinical investigation of this combination in hematologic malignancies.

Related Stories

Statins do not benefit patients with lung cancer, new study shows

February 27, 2017
Cholesterol-lowering drugs used alongside chemotherapy have no effect on treatment outcomes for lung cancer patients, according to a new study.

Cholesterol-lowering drugs may help patients with cirrhosis

September 7, 2017
Statins used for the treatment of high cholesterol may have other beneficial effects, but there has been reluctance to prescribe them to patients with liver disease because of concerns that they may cause abnormal liver enzyme ...

Study finds no link between statins and cancer risk

July 25, 2011
(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that, contrary to previous studies, the use of cholesterol reducing statin drugs does not increase the risk of patients ...

Older women taking statins face higher risk of diabetes

March 15, 2017
Older Australian women taking cholesterol-lowering statins face a significantly increased risk of developing diabetes, according to a University of Queensland study.

Genomic data could help doctors know whether to prescribe statins

September 29, 2014
Genomic data could predict whether statins will benefit a patient or not, according to an article in the open access journal Genome Biology. The research suggests that genomic data alone can explain around 15% of patients' ...

AHA: Evolocumab can help substantially reduce LDL

November 16, 2016
(HealthDay)—Combining statins with the PCSK9 inhibitor evolocumab can help reduce low-density lipoprotein (LDL) cholesterol to previously unseen levels, according to a study published online Nov. 15 in the Journal of the ...

Recommended for you

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Researchers find pathways that uncover insight into development of lung cancer

August 17, 2018
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants. One of these genetic components, ...

Developing an on-off switch for breast cancer treatment

August 17, 2018
T-cells play an important role in the body's immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using ...

Pregnant? Eating broccoli sprouts may reduce child's chances of breast cancer later in life

August 16, 2018
Researchers at the University of Alabama at Birmingham have found that a plant-based diet is more effective in preventing breast cancer later in life for the child if the mother consumed broccoli while pregnant. The 2018 ...

Scientists discover chemical which can kill glioblastoma cells

August 15, 2018
Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.